COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,044 Articles (22,627 medRxiv, 8,417 bioRxiv)

Most recent first Previous |  Page 2024: Articles 20231-20240  | Next

Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate
Patel, D. R., Field, C. J., Septer, K. M., SIm, D. G., Jones, M. J., Heinly, T. A., McGraw, E. A., Sutton, T. C.
10.1101/2020.11.20.392381 — Posted: 2020-11-22
Anti-COVID-19 efficacy of ivermectin in the golden hamster
de Melo, G. D., Lazarini, F., Larrous, F., Feige, L., Kergoat, L., Marchio, A., Pineau, P., Lecuit, M., Lledo, P.-M., Changeux, J.-P., Bourhy, H.
10.1101/2020.11.21.392639 — Posted: 2020-11-22
Community factors and excess mortality in first wave of the COVID-19 pandemic.
Davies, B., Parkes, B. L., Bennett, J., Fecht, D., Blangiardo, M., Ezzati, M., Elliott, P.
10.1101/2020.11.19.20234849 — Posted: 2020-11-22
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environment
Marotz, C., Belda-Ferre, P., Ali, F., Das, P., Huang, S., Cantrel, K., Jiang, L., Martino, C., Diner, R., Rahman, G., McDonald, D., Armstrong, G., Kodera, S., Donato, S., Ecklu-Mensah, G., Gottel, N., Salas Garcia, M., Chiang, L., Salido, R. A., Shaffer, J. P., Bryant, M., Sanders, K., Humphrey, G., Ackermann, G., Haiminen, N., Beck, K. L., Kim, H.-C., Carrieri, A. P., Parida, L., Vazquez-Baeza, Y., Torriani, F. J., Knight, R., Gilbert, J., Sweeney, D., Allard, S. M.
10.1101/2020.11.19.20234229 — Posted: 2020-11-22
At the dawn of winter: comparing COVID-19and influenza presentation and trajectory
Reiner Benaim, A., Sobel, J. A., Almog, R., Lugassy, S., Ben Shabbat, T., Johnson, A., Eytan, D., Behar, J. A.
10.1101/2020.11.19.20235077 — Posted: 2020-11-22
The Algerian chapter of SARS-CoV-2 pandemic: An evolutionary, genetic, and epidemiological prospect of the first wave.
Zeghbib, S., Somogyi, B., Zana, B., Kemenesi, G., Herczeg, R., Derrar, F., Jakab, F.
10.1101/2020.11.19.20235135 — Posted: 2020-11-22
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
Yang, H. S., Racine-Brzostek, S. E., Karbaschi, M., Yee, J., Dillard, A., Steel, P. A. D., Lee, W. S., McDonough, K. A., Qiu, Y., Ketas, T. J., Francomano, E., Klasse, P. J., Hatem, L., Westblade, L. F., Wu, H., Chen, H., Zuk, R., Tan, H., Girardin, R., Dupuis, A. P., Payne, A. F., Moore, J. P., Cushing, M. M., Chadburn, A., Zhao, Z.
10.1101/2020.11.19.20235044 — Posted: 2020-11-22
Statistical techniques to estimate the SARS-CoV-2 infection fatality rate
Mieskolainen, M., Bainbridge, R., Buchmueller, O., Lyons, L., Wardle, N.
10.1101/2020.11.19.20235036 — Posted: 2020-11-22 Discussion: Offsite
Association of HLA class I genotypes with age at death of COVID-19 patients
Shkurnikov, M., Nersisyan, S., Jankevic, T., Galatenko, A., Gordeev, I., Vechorko, V., Tonevitsky, A.
10.1101/2020.11.19.20234567 — Posted: 2020-11-22
Viruses such as SARS-CoV-2 can be partially shielded from UV radiation when in particles generated by sneezing or coughing: Numerical simulations
Doughty, D. C., Hill, S. C., Mackowski, D. W.
10.1101/2020.11.19.20233437 — Posted: 2020-11-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).